Death rates among seriously ill Covid-19 patients dropped sharply as doctors rejected the use of mechanical ventilators, analysis has found.
https://www.telegraph.co.uk/news/2020/09/03/covid-death-rates-dropped-doctors-rejected-ventilators/
Browse the articles related to this topic below.
Join our community on Guilded.
Death rates among seriously ill Covid-19 patients dropped sharply as doctors rejected the use of mechanical ventilators, analysis has found.
https://www.telegraph.co.uk/news/2020/09/03/covid-death-rates-dropped-doctors-rejected-ventilators/
As professor of epidemiology at Yale School of Public Health, I have authored over 300 peer-reviewed publications and currently hold senior positions on the editorial boards of several leading journals. I am usually accustomed to advocating for positions within the mainstream of medicine, so have been flummoxed to find that, in the midst of a crisis, I am fighting for a treatment that the data fully support but which, for reasons having nothing to do with a correct understanding of the science, has been pushed to the sidelines. As a result, tens of thousands of patients with COVID-19 are dying unnecessarily. Fortunately, the situation can be reversed easily and quickly.
I am referring, of course, to the medication hydroxychloroquine. When this inexpensive oral medication is given very early in the course of illness, before the virus has had time to multiply beyond control, it has shown to be highly effective, especially when given in combination with the antibiotics azithromycin or doxycycline and the nutritional supplement zinc.
https://web.archive.org/web/20200723155027/https://www.newsweek.com/key-defeating-covid-19-already-exists-we-need-start-using-it-opinion-1519535
https://www.ijidonline.com/article/S1201-9712(20)30534-8/fulltext
Dr. Harvey Risch, an epidemiology professor at Yale School of Public Health, said on Tuesday that he thinks hydroxychloroquine could save 75,000 to 100,000 lives if the drug is widely used to treat coronavirus.
“There are many doctors that I’ve gotten hostile remarks about saying that all the evidence is bad for it and, in fact, that is not true at all,” Risch told “Ingraham Angle,” adding that he believes the drug can be used as a “prophylactic” for front-line workers, as other countries like India have done.
Risch lamented that a “propaganda war” is being waged against the use of the drug for political purposes, not based on “medical facts.”
Researchers at the Henry Ford Health System in Southeast Michigan have found that early administration of hydroxychloroquine makes hospitalized patients substantially less likely to die.
https://www.foxnews.com/media/hydroxychloroquine-could-save-lives-ingraham-yale-professor
JRC Publishing LLC, New Jersey has published an important book on treatment of COVID-19 virus. The book is based on medical research and treatment conducted by Dr. Roland Derwand, Prof. Martin Scholz and Dr. Zelenko.
The compendium presents treatment process and detailed experiences of COVID-19 patients while undergoing medical care with Dr. Zelenko and his colleagues from around the world. This extensive work, covering 248 pages, offers unparalleled breath of medical research and is the first volume to be published in this field to date. The e-book is available for download and is being distributed free of charge.
https://internetprotocol.co/covid-19/2020/07/21/yale-harvard-professors-support-zelenkos-protocol/
Screenshot of article from News West 9 that has been taken down:
The Recovery trial has steadfastly ignored Professor Didier Raoult and a string of countries that have implemented his protocol, early use of HCQ with Azythromycin in safe doses, despite the fact that, after treating 3,737 patients — the single largest study in the world —Raoult has lost only 0.6 per cent, while Horby and Landray are presiding over carnage —a fatality rate of 25 per cent.
https://www.spectator.com.au/2020/06/bring-on-britains-corona-clowns/p>
More than 1.6 million Americans have been infected with SARS-CoV-2 and >10 times that number carry antibodies to it. High-risk patients presenting with progressing symptomatic disease have only hospitalization treatment with its high mortality. An outpatient treatment that prevents hospitalization is desperately needed. Two candidate medications have been widely discussed: remdesivir, and hydroxychloroquine+azithromycin. Remdesivir has shown mild effectiveness in hospitalized inpatients, but no trials have been registered in outpatients. Hydroxychloroquine+azithromycin has been widely misrepresented in both clinical reports and public media, and outpatient trials results are not expected until September. Early outpatient illness is very different than later hospitalized florid disease and the treatments differ. Evidence about use of hydroxychloroquine alone, or of hydroxychloroquine+azithromycin in inpatients, is irrelevant concerning efficacy of the pair in early high-risk outpatient disease. Five studies, including two controlled clinical trials, have demonstrated significant major outpatient treatment efficacy. Hydroxychloroquine+azithromycin has been used as standard-of-care in more than 300,000 older adults with multicomorbidities, with estimated proportion diagnosed with cardiac arrhythmias attributable to the medications 47/100,000 users, of which estimated mortality is <20%, 9/100,000 users, compared to the 10,000 Americans now dying each week. These medications need to be widely available and promoted immediately for physicians to prescribe.
https://academic.oup.com/aje/advance-article/doi/10.1093/aje/kwaa093/5847586
Note: The video has been removed from Vimeo but has been archived on BitChute (see embedded below highlights).
James talks with Professor Dolores Cahill, a world renowned immunologist who has advised the Irish government and the EU.
Shockingly, the UK government was not alone in pushing the crisis into care homes. In New York, the centre of the world’s worst outbreak, it is a similar story. Care homes were not only neglected for PPE and testing, but were also ordered to take in Covid patients. Homes could be fined $10,000 or lose their operating licence if they refused to comply with the rules. In Lombardy, the hardest-hit region of Italy, care homes were paid extra to take in Covid patients from hospitals.
The carnage in care homes ought to be the biggest scandal of the Covid crisis.
https://www.spiked-online.com/2020/05/19/how-covid-panic-caused-the-carnage-in-care-homes/
Care home residents confined to their rooms and forbidden visits from loved ones are giving up on life and “fading away”, say staff and families.
“The virus won’t be the killer of these people, it’s the distress and fear of not seeing family that is doing it,” said one carer who asked to remain anonymous but has reported her concerns to the Care Inspectorate in Scotland.
The argument that vitamin D deficiency may contribute to more severe cases of Covid is gaining ground. It is now reaching the point where it is surprising that we are not hearing from leading medical officials and politicians that people should consider taking supplements to ensure they have sufficient vitamin D.
https://www.spectator.co.uk/article/the-growing-evidence-on-vitamin-d-and-covid
Interview notes below the embedded video.
Dr. Wodarg is reassuring for anyone concerned about ‘the virus’. That danger is no greater than in any other flu season (now also based on tens of international leading scientists analyzing actual figures from all over the world). Wodarg’s message is disturbing when you wonder how the whole world can be fooled by such a clearly fact-free ‘panic’ allowing itself to be led to the curtailment of the most fundamental freedoms. A world that thinks it has to prepare itself for a ‘new normal’. In which incredibly dangerous and extremely undesirable ’solutions’ such as ‘mass vaccination’, ‘contact tracing’, and other ‘surveillance’ are seen as attractive.
Topics discussed:
It has become clear that a hard lockdown does not protect old and frail people living in care homes—a population the lockdown was designed to protect.3 Neither does it decrease mortality from COVID-19, which is evident when comparing the UK’s experience with that of other European countries.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31035-7/fulltext#%20
Intubation and ventilation were billed as the only way to treat Covid19 patients in the early days of the outbreak, but now some medical professionals are questioning the practice.
Perhaps it is not surprising, then, that according to this article 66% of UK Covid19 patients put on ventilators are dying. A recent study found that, in New York, 88% of ventilated Covid patients died. In Italy it was over 81%, in Wuhan it was 86%.
Conversely, South Korea has reported good early results treating Covid19 patients with other forms of oxygen therapy, or “non-invasive ventilation”.
The question arises: If ventilators are not recommended for respiratory infections, may do more damage than they prevent and are less effective than non-invasive ventilation, why are they being so widely used?
Well, one possible reason is that, according to the WHO guidelines, non-invasive ventilation could contribute to the spread of the virus via “aerosolisation”. This is repeated in guidelines from the CDC, ECDC and other national institutions.
The UK’s NHS goes one step further again, with their March 19th protocol actually calling mechanical ventilation the “preferred” option over non-invasive ventilation or other oxygen therapies.
This leaves wide open the possibility that hospitals are using treatments known to cause harm, simply to avoid the hypothetical spread of the virus.
Tens of thousands of stroke and heart patients are risking their lives by not getting symptoms checked out by a GP or avoiding hospital due to fears over Covid-19, i can reveal.
The 48-year-old physician, father of two and aspiring triathlete worried that an invasive ventilator would be harmful. But soon after entering the clinic, Bergmann said, he struggled to breathe even with an oxygen mask, and felt so sick the ventilator seemed inevitable.
Even so, his doctors never put him on a machine that would breathe for him. A week later, he was well enough to go home.
Bergmann’s case illustrates a shift on the front lines of the COVID-19 pandemic, as doctors rethink when and how to use mechanical ventilators to treat severe sufferers of the disease – and in some cases whether to use them at all. While initially doctors packed intensive care units with intubated patients, now many are exploring other options.